Neurontin and Vaginal infection - a phase IV clinical study of FDA data


Vaginal infection is found among people who take Neurontin, especially for people who are 40-49 old.

The phase IV clinical study analyzes which people take Neurontin and have Vaginal infection. It is created by eHealthMe based on reports of 100,481 people who have side effects when taking Neurontin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 09, 2022

100,481 people reported to have side effects when taking Neurontin.
Among them, 120 people (0.12%) have Vaginal infection.

What is Neurontin?

Neurontin has active ingredients of gabapentin. It is often used in neuralgia. eHealthMe is studying from 103,930 Neurontin users for its effectiveness, alternative drugs and more.

What is Vaginal infection?

Vaginal infection is found to be associated with 1,439 drugs and 772 conditions by eHealthMe.

Number of Neurontin and Vaginal infection reports submitted per year:

Could Neurontin cause Vaginal infection?

Age of people who have Vaginal infection when taking Neurontin *:

Click here to view

Common drugs people take besides Neurontin *:

Click here to view

Common side effects people have besides Vaginal infection *:

Click here to view

Common conditions people have *:

Click here to view

* Approximation only. Some reports may have incomplete information.

Do you take Neurontin and have Vaginal infection?

Check whether Vaginal infection is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Related studies

How severe was Vaginal infection and when was it recovered:

Expand to all the drugs that have ingredients of gabapentin:

Alternative drugs to, pros and cons of Neurontin:

Common Neurontin side effects:

Browse all side effects of Neurontin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Vaginal infection treatments and more:

COVID vaccines that are related to Vaginal infection:

Common drugs associated with Vaginal infection:

All the drugs that are associated with Vaginal infection:

Common conditions associated with Vaginal infection:

All the conditions that are associated with Vaginal infection:

How the study uses the data?

The study uses data from the FDA. It is based on gabapentin (the active ingredients of Neurontin) and Neurontin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: